Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine (2016)
- Authors:
- USP affiliated authors: SIMOES, BELINDA PINTO - FMRP ; COELHO, EDUARDO BARBOSA - FMRP ; LANCHOTE, VERA LUCIA - FCFRP
- Unidades: FMRP; FCFRP
- DOI: 10.1002/jcph.758
- Subjects: CÉLULAS-TRONCO; FARMACOCINÉTICA
- Keywords: PHARMACOKINETICS; BUSULFAN; FLUDARABINE; ORAL TEST DOSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: The Journal of Clinical Pharmacology
- ISSN: 0091-2700
- Volume/Número/Paginação/Ano: v. 56, n. 12, p. 1555-1562, 2016
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CASTRO, Francine Attié de et al. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine. The Journal of Clinical Pharmacology, v. 56, n. 12, p. 1555-1562, 2016Tradução . . Disponível em: https://doi.org/10.1002/jcph.758. Acesso em: 28 dez. 2025. -
APA
Castro, F. A. de, Simões, B. P., Godoy, A. L. P. C., Trigo, F. M. B., Coelho, E. B., & Lanchote, V. L. (2016). Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine. The Journal of Clinical Pharmacology, 56( 12), 1555-1562. doi:10.1002/jcph.758 -
NLM
Castro FA de, Simões BP, Godoy ALPC, Trigo FMB, Coelho EB, Lanchote VL. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 12): 1555-1562.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1002/jcph.758 -
Vancouver
Castro FA de, Simões BP, Godoy ALPC, Trigo FMB, Coelho EB, Lanchote VL. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 12): 1555-1562.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1002/jcph.758 - Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis
- Lercanidipine-fluvastatin interaction: pharmacokinetics stereoselectivity in experimental study
- Stereoselective 'alfa'-hydroxylation of metoprolol in hypertensive patients with renal failure
- Stereospecific pharmacodymamics/pharmacokinetics of metoprolol in rats
- Effect of CYP inhibitors on the stereoselective kinetic disposition of metoprolol in rats
- Stereoselective determination of citalopram by liquid chromatography-tandem mass spectrometry in human plasma for pharmacokinetic
- Chiral evaluation of fluvastatin in human plasma by high-performance liquid chromatography electrospray mass spectometry
- Enantioselective determination of mexiletine and its metabolites p-hydroxymexiletine and hydroxymethylmexiletine in rat plasma by normal-phase liquid chromatography-tandem mass spectrometry: application to pharmacokinetics
- Effect of hypertension on the stereoselective pharmacokinetics of fluvastatin in rats
- Enantioselectivity in fluvastatin-lercanidipine pharmacokinetics interaction in healthy volunteers
Informações sobre o DOI: 10.1002/jcph.758 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
